Alphavirus neoantigen vectors
US12109257B2 · kind B2 · utility
0Cited by
113References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 11, 2022 |
| Grant date | Oct 8, 2024 |
| Priority date | — |
| Expiry date | Oct 11, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/36143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are alphavirus vectors that include neoantigen-encoding nucleic acid sequences derived from a tumor of a subject. Also disclosed are nucleotides, cells, and methods associated with the vectors including their use as vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.